The company, which is flush with cash from sales of its market-leading GLP-1 franchise, has been an active dealmaker. ...

Group 1: Helios Consortium Offer - The Helios Consortium announced a cash offer to acquire the entire issued and to be issued share capital of CAB Payments Holdings plc, excluding shares already owned by Helios Fund III [1] - Eligible CAB Payments shareholders would receive US$1.15 in cash per existing share or a Partial Alternative Offer, with support from shareholders representing 52.70% of CAB Payments' issued share capital [2][22] Group 2: StoneX Proposal - StoneX Group Inc. approached CAB Payments regarding a potential acquisition, submitting a non-binding cash proposal subject to several pre-conditions [3] - The Helios Consortium declined to provide an irrevocable undertaking to support StoneX's proposal, leading to the conclusion that the Helios Offer is the only firm and deliverable offer available [4] Group 3: Regulatory Filings and CAB Board Response - The Helios Consortium is required to make regulatory filings that include specific non-public information about CAB Payments, referred to as Requisite Information [5] - The CAB Board has not recommended the Helios Offer and has refused to provide the Requisite Information, which the Helios Consortium believes is against the interests of CAB Payments shareholders [6][7] Group 4: Shareholder Engagement - The Helios Consortium encourages CAB Payments shareholders to urge the CAB Board to engage with them and relevant regulators to expedite the regulatory filing process [8] - The delay in providing the Requisite Information could lead to inefficiencies and disruptions to CAB Payments' business, negatively impacting all shareholders [7][8] Group 5: Shareholder Support - Helios Fund III owns or controls approximately 45.11% of CAB Payments' issued share capital, with additional support from Eurocomm and Bhairav Trivedi, bringing total support to approximately 52.70% [19][20][22] - The total issued share capital of CAB Payments is 254,143,218 shares as of 26 March 2026 [23]

Core Insights - Worthington Steel is pursuing its largest acquisition in history by acquiring Kloeckner, aiming to create a more diversified metals processing platform and unlock value through internal improvement programs [2][4] - The company reported a disciplined performance in Q3 fiscal 2026, with net sales of $769.8 million and adjusted earnings per share of $0.27, impacted by transaction-related fees and other one-time items [4][5] - Total shipments decreased by approximately 7% to around 818,000 tons, with a notable decline in toll processing but a 10% increase in automotive shipments [3][11] Acquisition and Integration - Management has initiated internal planning for the integration of Kloeckner, focusing on maintaining company cultures while preparing for "day one readiness" [1][4] - A voluntary public tender offer in Germany is underway, with management confident in meeting the 57.5% minimum share threshold required for the acquisition [1][4] Financial Performance - Q3 adjusted EBITDA was reported at $41.6 million, with net earnings of $10.4 million or $0.20 per share, down from $13.8 million or $0.27 per share in the prior-year quarter [5][6] - The company incurred $15.4 million in pre-tax SG&A expenses related to the Kloeckner acquisition, alongside other one-time financial impacts [8] Market Dynamics - The company experienced a decline in toll processing volumes by 22% year over year, attributed to the closure of the Cleveland facility and demand headwinds [14] - Direct sales increased, particularly in the automotive sector, which saw a 10% rise in shipments, reflecting gains from new programs and a return to normal production schedules by key automotive OEMs [12][13] Pricing and Inventory - Hot-rolled coil prices increased by approximately $175 per ton during the quarter, with expectations of continued volatility in steel prices due to market conditions [10] - The company anticipates pre-tax inventory holding gains of $15 million to $20 million in Q4 fiscal 2026, driven by lagging index-based pricing mechanisms [10] European Operations - Worthington Steel faced increased challenges in Europe, particularly in the electrical steel and automotive markets, leading to a decrease in CEDAM EBITDA by $8.4 million [15] - The company is implementing cost actions and operational adjustments to improve performance in the European market [15] Cash Flow and Capital Expenditures - Cash flow from operations was reported at $63 million, with free cash flow at $33 million, benefiting from a reduction in working capital [18] - Capital expenditures for the quarter were $30 million, with expectations for fiscal 2026 capex to be in the range of $110 million to $115 million [18] Share Purchases and Debt - Worthington Steel increased borrowings on its ABL by $126 million, using $101 million to purchase approximately 8.3 million shares of Kloeckner, representing about 8% of its shares [19] - The company ended the quarter with $90 million in cash and net debt of $161 million, primarily due to the Kloeckner share purchases [20]

Core Viewpoint - LakeShore Biopharma has received a revised preliminary non-binding proposal from Oceanpine Skyline Inc. to acquire all outstanding ordinary shares of the company at a reduced price of US$0.06 per share, which represents a 50% premium over the last trading price on March 20, 2026 [1][11]. Group 1: Proposal Details - The revised proposal aims to acquire all ordinary shares not owned by Oceanpine or its affiliates [1]. - The purchase price of US$0.06 per share reflects a premium of 50% over the last trading price [11]. - The proposal is influenced by recent financial liabilities imposed on the company, totaling approximately RMB576.5 million, which have adversely affected its financial condition [10][12]. Group 2: Evaluation Process - The Special Committee of LakeShore Biopharma will evaluate the proposed transaction with the help of financial and legal advisors [2]. - No decisions have been made regarding the proposal or any alternative strategic options [3]. Group 3: Company Background - LakeShore Biopharma is a global biopharmaceutical company focused on developing vaccines and therapeutic biologics for infectious diseases and cancer [4]. - The company operates in China, Singapore, and the Philippines, leveraging a proprietary PIKA® immunomodulating technology platform [4].

Core Viewpoint - The article argues that Paramount represents a more favorable deal compared to Netflix's previous attempts to acquire Warner Bros. Discovery, suggesting that Congress should proceed with supporting Paramount's position [2]. Group 1: Company Developments - Netflix has recently abandoned its efforts to acquire Warner Bros. Discovery after a lengthy bidding war and significant regulatory scrutiny [2]. - Some members of Congress, particularly those who opposed the Netflix-WBD deal, remain dissatisfied with the current situation [2]. Group 2: Industry Context - The competitive landscape in the media and entertainment industry is highlighted by the intense bidding war for Warner Bros. Discovery, indicating a high level of interest and investment in content acquisition [2]. - The involvement of major political figures, such as Larry Ellison's connections to President Donald Trump, suggests that political dynamics may influence corporate strategies and decisions in the industry [2].

Core Viewpoint - Aurinia Pharmaceuticals has undergone a significant leadership change with a complete overhaul of its C-suite, leading to a rally in its stock and speculation about potential acquisitions [1]. Group 1: Leadership Changes - Kevin Tang has been appointed as the new CEO, replacing Peter Greenleaf, who led the company for seven years [2]. - Alongside Tang, Ryan Cole has been appointed COO, Michael Hearns as CFO, and Thomas Wei as CSO, all of whom have connections to Tang Capital Management [4]. - Tang has a history of successfully leading companies through exits, including Ardea Biosciences and La Jolla Pharmaceutical [2]. Group 2: Market Reaction - Following the announcement, Aurinia's stock rose by 3.9%, closing at 14.56, and is consolidating with a buy point at 16.54 [3]. - The stock briefly surpassed its 50-day moving average, indicating positive market sentiment [3]. Group 3: Analyst Perspectives - RBC Capital Markets analyst Douglas Miehm views the leadership changes as "slightly positive" for the stock, noting Tang's ownership of approximately 9% of Aurinia's shares aligns his interests with those of shareholders [5]. - Miehm maintains a sector perform rating with a price target of 15, while acknowledging the near-term executive risk due to the simultaneous departure of four senior officers [6]. - Leerink Partners analyst Joseph Schwartz expressed interest in the new team's plans for enhancing shareholder value, given the company's positive cash flow [3][4].

Core Viewpoint - Genco Shipping & Trading Limited's Board of Directors unanimously rejected Diana Shipping Inc.'s revised proposal to acquire Genco shares at $23.50 per share, citing that the offer substantially undervalues the company and presents execution risks [1][5]. Valuation Concerns - The proposal is considered substantially below Genco's intrinsic value and fails to provide an appropriate premium to shareholders, especially given Genco's superior returns and strong market position [2][7]. - Diana's proposal referenced the lowest published NAV estimate from one analyst, which is below Genco's mean analyst NAV estimate of $25, indicating that the offer does not reflect the rising asset values [3][9]. Execution Risks - The proposal presents execution risks, as Diana's financing commitment of $1.433 billion is not fully supported by a commitment letter that only specifies $1.102 billion [4][13]. - The planned sale of 16 Genco vessels at discounted prices introduces further uncertainty and deprives Genco shareholders of full value [4][11]. Board's Position - The Board remains open to engaging with Diana if a revised offer appropriately reflects Genco's intrinsic value and potential in a strengthening market [5][15]. - Genco's Board has previously expressed willingness to explore alternative transactions that could benefit both companies, but Diana has not engaged in such discussions [14]. Financial Performance - Genco reported strong financial results, achieving multi-year highs in EBITDA and TCE, along with a Q4 2025 dividend of $0.50 per share, indicating robust operational performance [7][8]. - Over the past six years, Genco has distributed a total of $323 million in dividends, demonstrating a commitment to returning value to shareholders [8].

Core Viewpoint - StoneX has made a cash proposal of £241.4 million ($320.6 million) to acquire CAB Payments, offering 95 pence per share, which represents a 32% premium over CAB Payments' closing share price prior to the Helios Consortium's interest announcement [1][2]. Group 1: Acquisition Proposal - The offer from StoneX is 11% higher than the Helios Consortium's confirmed bid of 85 pence ($1.15) per share [2]. - StoneX believes its proposal allows CAB Payments shareholders to realize value in cash above recent trading prices and the existing Helios offer [2]. Group 2: Strategic Rationale - StoneX sees significant complementarity between its Payments business and CAB Payments, suggesting that a combination could create a leading global specialist in Emerging Markets payments [4]. - The company expresses confidence in being the best long-term owner and custodian of CAB Payments, with the potential to unlock additional opportunities for stakeholders [4]. Group 3: Previous Interactions - CAB Payments has previously rejected multiple approaches from Helios, which holds the largest stake in the company [3]. - As of now, neither CAB Payments nor Helios has responded to StoneX's latest acquisition proposal [3].

Group 1 - The acquisition saga surrounding Warner Bros. Discovery (WBD) has reached a resolution, with Paramount Skydance increasing its bid to $31 per share [2] - Netflix has withdrawn its bid for WBD's streaming and studio assets, leaving Paramount as the successful bidder [3] - WBD shareholders now face a decision: sell their shares at the current price in the upper $27 range or hold out for the $31 deal value [4] Group 2 - In March, WBD insiders sold over $200 million worth of stock, indicating a significant increase in insider selling compared to previous months [5] - CEO David Zaslav was the largest seller, reducing his holdings by 36% after selling approximately 4 million shares, yet he still retains shares worth nearly $200 million [6] - As the acquisition deal is set to be approved by regulators, there remains potential upside for WBD [7]

Core Viewpoint - Henkell Freixenet has acquired full ownership of Freixenet, increasing its stake from 50% to 100% through a mutual agreement with the founding Ferrer family and José Luis Bonet, although financial details of the transaction were not disclosed [1]. Group 1: Ownership and Transaction Details - Henkell Freixenet's acquisition of Freixenet marks the completion of a process that began in 2018 when Henkell & Co acquired 50.67% of Freixenet [1][2]. - Following a capital increase by José Ferrer Sala, he and José Luis Bonet collectively held 50% of Freixenet's share capital, with Henkell holding the other 50% prior to the full acquisition [2]. Group 2: Leadership and Future Plans - Andreas Brokemper, CEO of Henkell Freixenet, emphasized the evolution of a collaborative relationship into a unified team focused on developing the Freixenet brand and enhancing its international market position in the sparkling wine segment [3]. - Pedro Ferrer and José Luis Bonet will continue their roles as "honorary" presidents, with Ferrer also representing Freixenet in various institutions [3][4]. - The acquisition is expected to ensure continuity for Freixenet while enhancing its reputation and accelerating its growth as an international masterbrand [5].